Home Applications 213702 Application 213702
Type NDA
Sponsor PHARMA MAR USA INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ZEPZELCA LURBINECTEDIN INJECTABLE;INJECTION 4MG Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N213702-001 ZEPZELCA LURBINECTEDIN 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15
Orange Book patents# Current patent rows page 1 of 1 · 5 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N213702-001 7763615 2029-12-13 U-2836 Drug substance, Drug product 2020-06-23 N213702-001 7763615 2029-12-13 U-4299 Drug substance, Drug product 2020-06-23 N213702-001 12324806 2040-05-29 U-4212 2025-07-07 N213702-001 12433890 2040-05-29 U-4305 2025-11-06 N213702-001 12440490 2040-05-29 U-4252 2025-11-13
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N213702-001 ODE-304 2027-06-15 N213702-001 I-977 2028-10-02
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 84e616aacf4f…2026-08-18 06:07:40 2026-07 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 c0c555d07b60…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N213702-001 ZEPZELCA 4MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-06-15 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 2 · 60 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N213702-001 7763615 2029-12-13 U-4299 Drug substance, Drug product 2020-06-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213702-001 7763615 2029-12-13 U-2836 Drug substance, Drug product 2020-06-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213702-001 12324806 2040-05-29 U-4212 2025-07-07 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213702-001 12433890 2040-05-29 U-4305 2025-11-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213702-001 12440490 2040-05-29 U-4252 2025-11-13 84e616aacf4f…2026-08-18 06:07:40 2026-07 N213702-001 7763615 2029-12-13 U-4299 Drug substance, Drug product 2020-06-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213702-001 7763615 2029-12-13 U-2836 Drug substance, Drug product 2020-06-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213702-001 12324806 2040-05-29 U-4212 2025-07-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213702-001 12433890 2040-05-29 U-4305 2025-11-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213702-001 12440490 2040-05-29 U-4252 2025-11-13 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N213702-001 7763615 2029-12-13 U-4299 Drug substance, Drug product 2020-06-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213702-001 7763615 2029-12-13 U-2836 Drug substance, Drug product 2020-06-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213702-001 12324806 2040-05-29 U-4212 2025-07-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213702-001 12433890 2040-05-29 U-4305 2025-11-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213702-001 12440490 2040-05-29 U-4252 2025-11-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213702-001 7763615 2029-12-13 U-4299 Drug substance, Drug product 2020-06-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213702-001 7763615 2029-12-13 U-2836 Drug substance, Drug product 2020-06-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213702-001 12324806 2040-05-29 U-4212 2025-07-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213702-001 12433890 2040-05-29 U-4305 2025-11-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213702-001 12440490 2040-05-29 U-4252 2025-11-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N213702-001 7763615 2029-12-13 U-2836 Drug substance, Drug product 2020-06-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213702-001 12324806 2040-05-29 U-4212 2025-07-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213702-001 7763615 2029-12-13 U-2836 Drug substance, Drug product 2020-06-23 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N213702-001 7763615 2029-12-13 U-2836 Drug substance, Drug product 2020-06-23 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N213702-001 7763615 2029-12-13 U-2836 Drug substance, Drug product 2020-06-23 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N213702-001 7763615 2029-12-13 U-2836 Drug substance, Drug product 2020-06-23 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N213702-001 7763615 2029-12-13 U-2836 Drug substance, Drug product 2020-06-23 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N213702-001 7763615 2029-12-13 U-2836 Drug substance, Drug product 2020-06-23 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N213702-001 7763615 2029-12-13 U-2836 Drug substance, Drug product 2020-06-23 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N213702-001 7763615 2029-12-13 U-2836 Drug substance, Drug product 2020-06-23 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N213702-001 7763615 2029-12-13 U-2836 Drug substance, Drug product 2020-06-23 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N213702-001 7763615 2029-12-13 U-2836 Drug substance, Drug product 2020-06-23 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N213702-001 7763615 2029-12-13 U-2836 Drug substance, Drug product 2020-06-23 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N213702-001 7763615 2024-12-13 U-2836 Drug substance, Drug product 2020-06-23 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N213702-001 7763615 2024-12-13 U-2836 Drug substance, Drug product 2020-06-23 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N213702-001 7763615 2024-12-13 U-2836 Drug substance, Drug product 2020-06-23 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N213702-001 7763615 2024-12-13 U-2836 Drug substance, Drug product 2020-06-23 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N213702-001 7763615 2024-12-13 U-2836 Drug substance, Drug product 2020-06-23 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N213702-001 7763615 2024-12-13 U-2836 Drug substance, Drug product 2020-06-23 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N213702-001 7763615 2024-12-13 U-2836 Drug substance, Drug product 2020-06-23 5aa47cf7b7d7…
Observed Orange Book exclusivity history# Exclusivity history page 2 of 2 · 78 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 4 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 68727-712 ZEPZELCA Lurbinectedin Jazz Pharmaceuticals, Inc. NDA Current 68727-712 ZEPZELCA Lurbinectedin Jazz Pharmaceuticals, Inc. NDA Current 68727-712 ZEPZELCA Lurbinectedin Jazz Pharmaceuticals, Inc. NDA Current 68727-712 ZEPZELCA Lurbinectedin Jazz Pharmaceuticals, Inc. NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 85277 SUPPL 2026-03-06 85208 SUPPL 2026-03-03 83655 SUPPL 2025-10-03 83631 SUPPL 2025-10-02 82148 SUPPL 2025-05-05 82266 SUPPL 2025-04-30 74955 SUPPL 2023-07-31 74950 SUPPL 2023-07-31 70688 SUPPL 2022-04-05 70685 SUPPL 2022-04-04 63896 ORIG 2020-07-14 63576 ORIG 2020-06-16 63570 ORIG 2020-06-15